Short-Term Intravenous Sodium Nitrite Infusion Improves Cardiac and Pulmonary Hemodynamics in Heart Failure Patients

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 565-571

  Ormerod, Julian O M ^a   Arif, Sayqa ^a   Mukadam, Majid ^a   Evans, Jonathan D W ^a   Beadle, Roger ^a   Fernandez, Bernadette O ^c   Bonser, Robert S ^b   Feelisch, Martin ^c   Madhani, Melanie ^a,b   Frenneaux, Michael P ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

heart failure; hemodynamics; methemoglobinemia; nitric oxide; nitrite

Indexed keywords

SODIUM NITRITE; VASODILATOR AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE VOLUME; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HUMAN; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; METHEMOGLOBINEMIA; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SHORT COURSE THERAPY; SYSTEMIC VASCULAR RESISTANCE; VASCULAR RESISTANCE; VASODILATATION; CHRONIC DISEASE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; DRUG ADMINISTRATION; DRUG EFFECTS; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; ARTERIAL PRESSURE; CARDIAC OUTPUT; CHRONIC DISEASE; CORONARY CIRCULATION; DRUG ADMINISTRATION SCHEDULE; ENGLAND; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PULMONARY CIRCULATION; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SODIUM NITRITE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 84942861931     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001716     Document Type: Article

References (36)

1. Siddiqi N, Singh S, Beadle R, Dawson D, Frenneaux M. Cardiac metabolism in hypertrophy and heart failure: implications for therapy. Heart Fail Rev. 2013;18:595-606. doi: 10.1007/s10741-012-9359-2.
2. Fitchett DH, Simkus GJ, Beaudry JP, Marpole DG. Reflected pressure waves in the ascending aorta: effect of glyceryl trinitrate. Cardiovasc Res. 1988;22:494-500.
3. Elkayam U, Mehra A, Shotan A, Osprzega E. Possible mechanisms of nitrate tolerance. Am J Cardiol. 1992; 70:49G-53G; discussion 53G.
4. Liu LC, Voors AA, Valente MA, van der Meer P. A novel approach to drug development in heart failure: towards personalized medicine. Can J Cardiol. 2014;30:288-295. doi: 10.1016/j.cjca.2013.12.005.
5. Pöss J, Link A, Böhm M. Pharmacological treatment of acute heart failure: current treatment and new targets. Clin Pharmacol Ther. 2013;94:499-508. doi: 10.1038/clpt.2013.136.
6. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, Thomas P, Ashrafian H, Born GV, James PE, Frenneaux MP. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation. 2008;117:670-677. doi: 10.1161/CIRCULATIONAHA.107.719591.
7. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, Partovi K, Pelletier MM, Oldfield EH, Cannon RO III, Schechter AN, Gladwin MT. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation. 2007;116:1821-1831. doi: 10.1161/CIRCULATIONAHA.107.712133.
8. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO III, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9:1498-1505. doi: 10.1038/nm954.
9. Casey DB, Badejo AM Jr, Dhaliwal JS, Murthy SN, Hyman AL, Nossaman BD, Kadowitz PJ. Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat. Am J Physiol Heart Circ Physiol. 2009;296:H524-H533. doi: 10.1152/ajpheart.00543.2008.
10. Ingram TE, Pinder AG, Bailey DM, Fraser AG, James PE. Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol. 2010;298:H331-H339. doi: 10.1152/ajpheart.00583.2009.
11. Maher AR, Arif S, Madhani M, Abozguia K, Ahmed I, Fernandez BO, Feelisch M, O'Sullivan AG, Christopoulos A, Sverdlov AL, Ngo D, Dautov R, James PE, Horowitz JD, Frenneaux MP. Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. Br J Pharmacol. 2013;169:659-670. doi: 10.1111/bph.12152.
12. Najjar SS, Schulman SP, Gerstenblith G, Fleg JL, Kass DA, O'Connor F, Becker LC, Lakatta EG. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol. 2004;44:611-617. doi: 10.1016/j.jacc.2004.04.041.
13. Rassaf T, Bryan NS, Kelm M, Feelisch M. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med. 2002;33:1590-1596.
14. Morris-Thurgood JA, Frenneaux MP. Pacing in congestive heart failure. Curr Control Trials Cardiovasc Med. 2000;1:107-114. doi: 10.1186/cvm-1-2-107.
15. Pluta RM, Oldfield EH, Bakhtian KD, Fathi AR, Smith RK, Devroom HL, Nahavandi M, Woo S, Figg WD, Lonser RR. Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One. 2011;6:e14504. doi: 10.1371/journal.pone.0014504.
16. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, Tyberg JV, Frenneaux MP. Diastolic ventricular interaction in chronic heart failure. Lancet. 1997;349:1720-1724. doi: 10.1016/S0140-6736(96)05109-4.
17. Tyberg JV, Taichman GC, Smith ER, Douglas NW, Smiseth OA, Keon WJ. The relationship between pericardial pressure and right atrial pressure: an intraoperative study. Circulation. 1986;73:428-432.
18. Moore TD, Frenneaux MP, Sas R, Atherton JJ, Morris-Thurgood JA, Smith ER, Tyberg JV, Belenkie I. Ventricular interaction and external constraint account for decreased stroke work during volume loading in CHF. Am J Physiol Heart Circ Physiol. 2001;281:H2385-H2391.
19. Angelone T, Gattuso A, Imbrogno S, Mazza R, Tota B. Nitrite is a positive modulator of the Frank-Starling response in the vertebrate heart. Am J Physiol Regul Integr Comp Physiol. 2012;302:R1271-R1281. doi: 10.1152/ajpregu.00616.2011.
20. Pellegrino D, Shiva S, Angelone T, Gladwin MT, Tota B. Nitrite exerts potent negative inotropy in the isolated heart via eNOS-independent nitric oxide generation and cGMP-PKG pathway activation. Biochim Biophys Acta. 2009;1787:818-827. doi: 10.1016/j.bbabio.2009.02.007.
21. Bhushan S, Kondo K, Polhemus DJ, Otsuka H, Nicholson CK, Tao YX, Huang H, Georgiopoulou VV, Murohara T, Calvert JW, Butler J, Lefer DJ. Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling. Circ Res. 2014;114:1281-1291. doi: 10.1161/CIRCRESAHA.114.301475.
22. Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH. Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. J Am Coll Cardiol. 1985;5:731-737.
23. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A. Randomised trial of high-dose isosorbide dinitrate plus lowdose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351:389-393. doi: 10.1016/S0140-6736(97)08417-1.
24. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, Blatt A, Simovitz A, Shaham O, Faigenberg Z, Metzger M, Stav D, Yogev R, Golik A, Krakover R, Vered Z, Cotter G. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol. 2000;36:832-837.
25. Manyari DE, Wang Z, Cohen J, Tyberg JV. Assessment of the human splanchnic venous volume-pressure relation using radionuclide plethysmography. Effect of nitroglycerin. Circulation. 1993;87:1142-1151.
26. Chihara E, Manyari DE, Isaac DL, Tyberg JV. Comparative effects of nitroglycerin on intestinal vascular capacitance and conductance. Can J Cardiol. 2002;18:165-174.
27. Rabinowitz B, Tamari I, Elazar E, Neufeld HN. Intravenous isosorbide dinitrate in patients with refractory pump failure and acute myocardial infarction. Circulation. 1982;65:771-778.
28. Armstrong PW, Armstrong JA, Marks GS. Pharmacokinetichemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation. 1980;62:160-166.
29. Dupuis J, Lalonde G, Lebeau R, Bichet D, Rouleau JL. Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J. 1990;120:625-637.
30. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301:H2181-H2190. doi: 10.1152/ajpheart.00554.2011.
31. Chirkov YY, Horowitz JD. Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier Pharmacol Ther. 2007;116:287-305. doi: 10.1016/j.pharmthera.2007.06.012.
32. Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ROS signalling in heart failure. Basic Res Cardiol. 2013;108:359. doi: 10.1007/s00395-013-0359-8.
33. Perlman DH, Bauer SM, Ashrafian H, Bryan NS, Garcia-Saura MF, Lim CC, Fernandez BO, Infusini G, McComb ME, Costello CE, Feelisch M. Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res. 2009;104:796-804. doi: 10.1161/CIRCRESAHA.108.187005.
34. Okamoto T, Tang X, Janocha A, Farver CF, Gladwin MT, McCurry KR. Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2013;145:1108-1116. doi: 10.1016/j. jtcvs.2012.04.006.
35. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M; International AHFS Working Group. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010;3:314-325. doi: 10.1161/CIRCHEARTFAILURE.109.893222.
36. Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M; RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet. 2013;381:29-39. doi: 10.1016/S0140-6736(12)61855-8.